Jennifer Smith
Family · Hattiesburg, MSNPI 1780354217
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 34.7% of the total. Reporting peaked in 2022 at $2,198 and has fallen 98.8% since, to $26 in 2025. Among family clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- ANI Pharmaceuticals, Inc.$429
- Novartis$418
- Johnson & Johnson$260
- Mallinckrodt Hospital Products Inc.$194
- plus $795 from 16 others
What the payments were for
- Food & beverage$4,90398%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $1,743 |
| Amgen(2 entities) | 59 | $1,179 |
| ANI Pharmaceuticals, Inc. | 18 | $429 |
| Novartis | 21 | $418 |
| Johnson & Johnson | 11 | $260 |
| Mallinckrodt Hospital Products Inc. | 7 | $194 |
| Pfizer | 7 | $123 |
| Lilly USA, LLC | 5 | $109 |
| AstraZeneca | 5 | $93 |
| Fidia Pharma USA Inc. | 3 | $65 |
| GSK | 4 | $62 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Medtronic | 2 | $42 |
| UCB, Inc. | 2 | $40 |
| Radius Health, Inc. | 2 | $40 |
| Sanofi | 1 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Qiagen, LLC | 1 | $17 |
How this compares
$5,018 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Leflunomide | 19 | $986 |
| Hydroxychloroquine Sulfate | 34 | $867 |
| MethotrexateMethotrexate Sodium | 40 | $755 |
| Gabapentin | 35 | $447 |
| Diclofenac Sodium | 21 | $257 |
| Allopurinol | 30 | $190 |
| Duloxetine Hcl | 11 | $151 |
| Tramadol Hcl | 22 | $148 |
| Pregabalin | 12 | $142 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $135 |
| Celecoxib | 17 | $105 |
| Tizanidine Hcl | 14 | $82 |
| Prednisone | 25 | $69 |
| Alendronate Sodium | 12 | $58 |
| Meloxicam | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other family in Hattiesburg
- Erin RobertsHattiesburg$12K
- Victoria FordHattiesburg$11K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.